Amaze: a double-blind, multicentre randomised controlled trial to investigate the clinical effectiveness and cost-effectiveness of adding an ablation device-based maze procedure as an adjunct to routine cardiac surgery for patients with pre-existing atrial fibrillation.

Sharples, L; Everett, C; Singh, J; Mills, C; Spyt, T; Abu-Omar, Y; Fynn, S; Thorpe, B; Stoneman, V; Goddard, H; +2 more... Fox-Rushby, J; Nashef, S; (2018) Amaze: a double-blind, multicentre randomised controlled trial to investigate the clinical effectiveness and cost-effectiveness of adding an ablation device-based maze procedure as an adjunct to routine cardiac surgery for patients with pre-existing atrial fibrillation. Health technology assessment (Winchester, England), 22 (19). pp. 1-132. ISSN 1366-5278 DOI: https://doi.org/10.3310/hta22190

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.3310/hta22190

Abstract

Share

Download

Filename: Amaze.pdf

Licence: Copyright the publishers

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar